Katherine M. Aird, Ph.D.
Affiliations: | 2010 | Pathology | Duke University, Durham, NC |
Area:
Cell BiologyGoogle:
"Katherine Aird"Parents
Sign in to add mentor| Gayathri R. Devi | grad student | 2010 | Duke | |
| (Role of X-linked inhibitor of apoptosis protein in therapeutic resistance of inflammatory breast cancer cells.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Chang C, Cheng YY, Kamlapurkar S, et al. (2024) GPX3 supports ovarian cancer tumor progression and promotes expression of GDF15. Biorxiv : the Preprint Server For Biology |
| Chang C, Cheng YY, Kamlapurkar S, et al. (2024) GPX3 supports ovarian cancer tumor progression in vivo and promotes expression of GDF15. Gynecologic Oncology. 185: 8-16 |
| Bapat J, Yamamoto TM, Woodruff ER, et al. (2023) CASC4/GOLM2 drives high grade serous carcinoma anoikis resistance through the recycling of EGFR. Cancer Gene Therapy |
| Sharrow AC, Ho M, Buj R, et al. (2023) Tumor-Associated Macrophages Expand Chemoresistant, Ovarian Cancer Stem-Like Cells. Biorxiv : the Preprint Server For Biology |
| Oesterreich S, Aird KM. (2023) Senescence and Immunotherapy: Redundant Immunomodulatory Pathways Promote Resistance. Cancer Immunology Research. OF1-OF4 |
| Huang Z, Chen CW, Buj R, et al. (2022) ATM inhibition drives metabolic adaptation via induction of macropinocytosis. The Journal of Cell Biology. 222 |
| Veenstra JP, Bittencourt LFF, Aird KM. (2022) The Senescence-Associated Secretory Phenotype in Ovarian Cancer Dissemination. American Journal of Physiology. Cell Physiology |
| Leon KE, Buj R, Lesko E, et al. (2021) DOT1L modulates the senescence-associated secretory phenotype through epigenetic regulation of IL1A. The Journal of Cell Biology. 220 |
| Buj R, Leon KE, Anguelov MA, et al. (2021) Suppression of p16 alleviates the senescence-associated secretory phenotype. Aging. 13 |
| Aronson MR, Dahl ES, Halle JA, et al. (2020) Re-engineering Antimicrobial Peptides into Oncolytics Targeting Drug-Resistant Ovarian Cancers. Cellular and Molecular Bioengineering. 13: 447-461 |